bioRxivGeneticsPreprint
A novel inducible von Willebrand Factor Cre Recombinase mouse strain to study microvascular endothelial cell-specific biological processes in vivo.
Dinesh Kumar YadaviD, Jeremy A. Conner, Yimin WangiD, Thomas L. SaundersiD, Eroboghene E. UboguiD
Abstract
Mouse models are invaluable to understanding fundamental mechanisms in vascular biology during development, in health and different disease states. Several constitutive or inducible models that selectively knockout or knock in genes in vascular endothelial cells exist; however, functional and phenotypic differences exist between microvascular and macrovascular endothelial cells in different organs. In order to study microvascular endothelial cell-specific biological processes, we developed a Tamoxifen-inducible von Willebrand Factor (vWF) Cre recombinase mouse in the SJL background. The transgene consists of the human vWF promoter with the microvascular endothelial cell-selective 734 base pair sequence to drive Cre recombinase fused to a mutant estrogen ligand-binding domain [ERT2] that requires Tamoxifen for activity (CreERT2) followed by a polyadenylation (polyA) signal. We initially observed Tamoxifen-inducible restricted bone marrow megakaryocyte and sciatic nerve microvascular endothelial cell Cre recombinase expression in offspring of a mixed strain hemizygous C57BL/6- SJL founder mouse bred with mT/mG mice, with >90% bone marrow megakaryocyte expression efficiency. Founder mouse offspring were backcrossed to the SJL background by speed congenics, and intercrossed for >10 generations to develop hemizygous Tamoxifen-inducible vWF Cre recombinase (vWF-iCre/+) SJL mice with stable transgene insertion in chromosome 1. Microvascular endothelial cell-specific Cre recombinase expression occurred in the sciatic nerves, brains, spleens, kidneys and gastrocnemius muscles of adult vWF-iCre/+ SJL mice bred with Ai14 mice, with retained low level bone marrow and splenic megakaryocyte expression. This novel mouse strain would support hypothesis-driven mechanistic studies to decipher the role(s) of specific genes transcribed by microvascular endothelial cells during development, as well as in physiologic and pathophysiologic states in an organ- and time-dependent manner.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Generation of a novel constitutive smooth muscle cell-specific Myh11-driven Cre mouse model
Kunzhe Dong, Zhixia Bai, … Jiliang Zhou·bioRxiv·Nov 8, 2024
- An Inducible Cre Mouse with Preferential Activity in Vascular Smooth Muscle Evades a Previously Lethal Intestinal Phenotype
Ganesh Warthi, Jessica Faulkner, … Joseph M. Miano·bioRxiv·Feb 3, 2022
- An endothelial-specific TIE2-L914F mouse model reveals cellular mechanisms of venous malformation progression and recapitulates the patient's response to targeted therapy
Lindsay J. Bischoff, Sandra Schrenk, … Elisa Boscolo·bioRxiv·Oct 30, 2026
- Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling
Lindsay J. Bischoff, Sandra Schrenk, … Elisa Boscolo·Developmental DynamicsPeer-reviewed·Oct 11, 2025
- CreER activation transiently impairs angiogenesis by slowing endothelial proliferation
Elena Ioannou, Mengmeng Dong, … Martina Rudnicki·bioRxiv·May 22, 2025
- Constitutive, mosaic expression of TIE2 p.L914F during mouse development causes formation of venous malformation
Lindsay J. Bischoff, Chhiring Sherpa, … Elisa Boscolo·The FASEB JournalPeer-reviewed·Apr 30, 2026